Wilmington Savings Fund Society FSB Sells 5,149 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Wilmington Savings Fund Society FSB lowered its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 94,806 shares of the medical instruments supplier’s stock after selling 5,149 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Merit Medical Systems were worth $9,170,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Conestoga Capital Advisors LLC raised its holdings in Merit Medical Systems by 1.7% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,289,148 shares of the medical instruments supplier’s stock valued at $226,236,000 after buying an additional 38,780 shares during the last quarter. State Street Corp increased its position in shares of Merit Medical Systems by 0.7% in the third quarter. State Street Corp now owns 2,231,701 shares of the medical instruments supplier’s stock valued at $220,559,000 after acquiring an additional 15,098 shares during the period. FMR LLC raised its stake in shares of Merit Medical Systems by 70.1% during the third quarter. FMR LLC now owns 1,577,246 shares of the medical instruments supplier’s stock valued at $155,879,000 after acquiring an additional 649,799 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Merit Medical Systems by 1.3% during the third quarter. Geode Capital Management LLC now owns 1,357,265 shares of the medical instruments supplier’s stock worth $134,165,000 after purchasing an additional 17,490 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Merit Medical Systems by 8.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 727,340 shares of the medical instruments supplier’s stock valued at $71,883,000 after purchasing an additional 54,122 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. StockNews.com downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Barrington Research increased their target price on Merit Medical Systems from $114.00 to $115.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 29th. Raymond James upped their price target on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 31st. Needham & Company LLC boosted their target price on shares of Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Finally, Robert W. Baird lifted their price target on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $109.80.

Insider Buying and Selling

In other Merit Medical Systems news, Director F. Ann Millner sold 12,500 shares of Merit Medical Systems stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.55, for a total value of $1,269,375.00. Following the completion of the sale, the director now owns 32,391 shares of the company’s stock, valued at approximately $3,289,306.05. The trade was a 27.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 3.70% of the stock is owned by corporate insiders.

Merit Medical Systems Stock Up 0.1 %

Merit Medical Systems stock opened at $109.12 on Friday. The firm has a market cap of $6.36 billion, a price-to-earnings ratio of 53.49, a PEG ratio of 2.42 and a beta of 0.87. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57. Merit Medical Systems, Inc. has a 12 month low of $70.70 and a 12 month high of $111.45. The stock has a fifty day simple moving average of $101.88 and a two-hundred day simple moving average of $97.91.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.